Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance

  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Vinblastine Sulphate Injection 10 mg
  Indications :
 

Frequently Responsive Malignancies

Generalized Hodgkin's disease (Stages III & IV).

Lymphocytic lymphoma (nodular and diffuse, poorly and well differentiated).

Histiocytic lymphoma.

Mycosis fungoides (advanced stages).

Advanced carcinoma of the testis (embryonal carcinoma, teratocarcinoma & choriocarcinoma).

Kaposi's sarcoma.


Less Frequently Responsive Malignancies

Choriocarcinoma resistant to other chemotherapeutic agents.

Carcinoma of the breast, unresponsive to appropriate endocrine surgery & hormonal therapy.

   
  Dosage :
  Adults : A single IV dose of 3.7 mg/m2 of body surface area.

Children : 2.5 mg/m2 of body surface area.

Dosage Adjustment :

Renal Impairment : Not Required

Hepatic Impairment : Required
   
  Packing : 10 Vials of 10 mg/10 ml
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.